This is a permanent results page for your analyzed data. Please save the link in your browser's address bar.
| Title / Description | Gefitinib effect on various non-small cell lung cancer cell lines (HG-U133B) |
| Accession | GDS2298 |
| Summary | Analysis of baseline non-small cell lung cancer (NSCLC) cell lines with a broad range of sensitivity to the anticancer drug gefitinib. Gefitinib is an epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI). Results used to define a gene expression signature of gefitinib sensitivity. |
| Organism | Homo sapiens |
| Platform | GPL97 |
| Normalized | False |
| Parsed SOFT file |
| Differential expression method | Characteristic Direction |
| Cutoff | 500 |
| Cell | nonsmall cell lung cancer cell lines |
| Perturbation | gefitinib |
| Disease | non-small cell lung cancer |
| Principal Component Analysis | |
| Hierarchical clustering |
| Gene lists | Enrichr | L1000CDS2 | PAEA | |
| Up |
|
|||
| Down |
|
|||
| Combined |
|
|
|
